feed
S&P 500
NASDAQ
DOW
VIX
US10Y
EUR/USD
GOLD
WTI
BTC
AArphra
Arphra/Issuer/LALPATHLAB.NS

LALPATHLAB.NS

Dr. Lal PathLabs Limited
HealthcareMedical - Diagnostics & ResearchININRCountry macro →
$1,561.00
Jun 02, 2026
AI Brief
Revenue · FY
$27.63B
Net income
$5.05B
FY 2026
EPS · diluted
$30.20
EBITDA
$7.83B

Explain this page

Arphra AI
Max

AI investment thesis

Arphra AI-generated investment theses are included with Max.

Upgrade to Max